An open label, single arm trial to evaluate patients with metastatic renal cell carcinoma treated with everolimus after failure of first line therapy with sunitinib or pazopanib

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2011
This article has no abstract
Epistemonikos ID: 65778bf68b4d28c3ed00dbcafc7d16150814fcc7
First added on: Jan 22, 2025